S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter

Anke Bahrmann; Philipp Bahrmann; Jeannette Baumann; Jürgen Bauer; Elke Brückel; Manfred Dreyer; Michael Freitag; Alexander Friedl; Stefan Gölz; Susanne Grundke; Sonja Hiddemann; Katja Hodeck; Werner Kern; Ulrich Kintscher; Thomas Kubiak; Bernhard Kulzer; Young Hee Lee-Barkey; Ralf Lobmann; Nikolaus Marx; Frank Schröder; Astrid Tombek; Til Uebel; Jürgen Wernecke; Andrej Zeyfang

doi:10.1055/a-0666-0820

Diabetologie und Stoffwechsel, Inhaltsverzeichnis

Diabetologie und Stoffwechsel 2018; 13(05): 423-489
DOI: 10.1055/a-0666-0820

Leitlinie

S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter

2. Auflage 2018 – AWMF-Register-Nr. 057-017

Anke Bahrmann

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Philipp Bahrmann

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Jeannette Baumann

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Jürgen Bauer

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Elke Brückel

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Manfred Dreyer

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Michael Freitag

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Alexander Friedl

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Stefan Gölz

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Susanne Grundke

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Sonja Hiddemann

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Katja Hodeck

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Werner Kern

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Ulrich Kintscher

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Thomas Kubiak

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Bernhard Kulzer

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Young Hee Lee-Barkey

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Ralf Lobmann

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Nikolaus Marx

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Frank Schröder

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Astrid Tombek

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Til Uebel

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Jürgen Wernecke

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

,

Andrej Zeyfang

medius KLINIK OSTFILDERN-RUIT, Klinik für Innere Medizin, Altersmedizin und Palliativmedizin, Ostfildern

› Institutsangaben

Abstract

Zusammenfassung

Die Diabetesprävalenz liegt in der Altersgruppe ab 80 Jahren bei über 30 %. Bei der Diagnostik und Therapie älterer Menschen mit Typ-1- und Typ-2 Diabetes müssen altersspezifische Besonderheiten wie funktionelle und kognitive Einschränkungen sowie Komorbiditäten und Aspekte der Polypharmazie in besonderem Maße berücksichtigt werden. Die S2k-Leitlinie der Deutschen Diabetes Gesellschaft wurde mit 6 weiteren Fachgesellschaften (Deutsche Gesellschaft für Kardiologie, Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin, Deutsche Gesellschaft für Geriatrie, Deutsche Gesellschaft für Ernährungsmedizin, Deutsche Gesellschaft für Pflegewissenschaft, Deutsche Gesellschaft für Palliativmedizin) und der Patientenvertretung (DBW) erarbeitet. Therapieziele wie Erhalt der Lebensqualität und strikte Vermeidung von Akutkomplikationen wie schwere Hypoglykämien treten in den Vordergrund. HbA1c-Ziele sollten gemeinsam mit den Patienten in Abhängigkeit der individuellen Wünsche und Fähigkeiten festgelegt werden. Altersspezifische Besonderheiten einzelner Medikamente müssen insbesondere im Kontext der Multimorbidität beachtet werden. In der Leitlinie werden pflegerische Aspekte, Schnittstellenmanagement, Schmerztherapie sowie häufige Komorbiditäten bei Diabetes wie Hypertonie, Frailty, Sarkopenie, Demenz, Depression, End-of-Life Situationen ausführlich dargestellt.

Abstract

Diabetes prevalence is over 30 % in the age group 80 years and older. In diagnostic and treatment of older people with type-1 and type-2 diabetes, age-specific features such as functional and cognitive deficits as well as comorbidities and aspects of polypharmacy must be taken into account. The S2k-guideline of the German Diabetes Association was developed together with six other medical societies (German Cardiac Society, German College of General Practitioners and Family Physicians, German Society for Geriatrics, German Society for Nutritional Medicine, German Society for Nursing Science, German Association for Palliative Medicine) and Patient Representation [DBW]): Main therapeutic goals in elderly diabetes patients are maintenance of quality of life and strict avoidance of acute complications (e.g. severe hypoglycemia). HbA1c goals consider both patients` preference and abilities. Age-specific features of diabetes medications must be taken into account, especially in the context of multimorbidity. The guideline describes in detail nursing aspects, interface management, pain therapy as well as frequent comorbidities in diabetes such as hypertension, frailty, sarcopenia, dementia, depression, end-of-life situations.

Schlüsselwörter

Leitlinie - Diabetes im Alter - Geriatrie - ältere Patienten - funktionelle Einschränkungen

Key words

guideline - diabetes in old age - geriatrics - older patients - functional limitations

Volltext

Referenzen

Literatur
1 Statistisches Bundesamt. Bevölkerung Deutschlands bis 2060. Ergebnisse der 13. koordinierten Bevölkerungsvorausberechnung. Im Internet: http://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/VorausberechnungBevoelkerung/BevoelkerungDeutschland2060_5124202159004.pdf?__blob=publicationFile ; Stand: 08.06.2017
2 Statistisches Bundesamt. Pflegebedürftige (absolut, je 100.000 Einwohner, in Prozent). Gliederungsmerkmale: Jahre, Region, Alter, Geschlecht, Pflegestufe, Art der Betreuung. Im Internet: http://www.gbe-bund.de (Stand: 31.03.2015)
3 Tamayo T, Brinks R, Hoyer A. et al. The Prevalence and Incidence of Diabetes in Germany. Dtsch Arztebl Int 2016; 113 (11) 177-182 . doi:10.3238/arztebl.2016.0177
4 Meisinger C, Strassburger K, Heier M. et al. Prevalence of undiagnosed diabetes and impaired glucose regulation in 35–59-year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med 2010; 27 (03) 360-362 . doi:10.1111/j.1464-5491.2009.02905.x
5 Neuhauser HK, Adler C, Rosario AS. et al. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–2011. J Hum Hypertens 2015; 29 (04) 247-253 . doi:10.1038/jhh.2014.82
6 Boehme MWJ, Buechele G, Frankenhauser-Mannuss J. et al. Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany-a retrospective cohort and case control study in claims data of a large statutory health insurance. BMC Public Health 2015; 15: 855 . doi:10.1186/s12889-015-2188-1
7 Prinz N, Stingl J, Dapp A. et al. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry. Diabetes Res Clin Pract 2016; 112: 73-81 . doi:10.1016/j.diabres.2015.10.026
8 Szendroedi J, Saxena A, Weber KS. et al. Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol 2016; 15: 59 . doi:10.1186/s12933-016-0374-9
9 Simmons RK, Rahman M, Jakes RW. et al. Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort. Diabetologia 2011; 54 (02) 312-319 . doi:10.1007/s00125-010-1949-8
10 Griffin SJ, Borch-Johnsen K, Davies MJ. et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011; 378: 156-167 . doi:10.1016/S0140-6736(11)60698-3
11 Simmons RK, Echouffo-Tcheugui JB, Sharp SJ. et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012; 380: 1741-1748 . doi:10.1016/S0140-6736(12)61422-6
12 Agency for Healthcare Research and Quality. Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation: AHRQ Publication No. 13-05190-EF-1 2015.
13 Sinclair A, Dunning T, Colagiuri S. International Diabetes Federation. Managing older people with type 2 diabetes. Global guideline. Bruselas, Bélgica: International Diabetes Federation; 2013
14 Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Hausärztliche Risikoberatung zur kardiovaskulären Prävention. S3-Leitlinie. 2017 Im Internet: http://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-024_Risikoberatung%20kardiovaskul.%20Praevention/053-024l_Hausaerztliche%20Risikoberat%20kardiovask%20Praevention_korr_12-1-18.pdf ; Stand: 14.05.2018
15 Zeyfang A, Berndt S, Aurnhammer G. et al. A short easy test can detect ability for autonomous insulin injection by the elderly with diabetes mellitus. J Am Med Dir Assoc 2012; 13 (01) 81.e15–18 . doi:10.1016/j.jamda.2010.10.006
16 Petrie D, Lung TWC, Rawshani A. et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia 2016; 59 (06) 1167-1176 . doi:10.1007/s00125-016-3914-7
17 Lachin JM. Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population. Diabetes Care 2016; 39 (08) 1378-1383 . doi:10.2337/dc15-2399
18 Seissler J. Latent (slowly progressing) autoimmune diabetes in adults. Curr Diab Rep 2008; 8 (02) 94-100 . doi:10.1007/s11892-008-0018-x
19 Shulman KI, Shedletsky R, Silver IL. The challenge of time. Clock-drawing and cognitive function in the elderly. Int J Geriatr Psychiatry 1986; 1 (02) 135-140 . doi:10.1002/gps.930010209
20 Kalbe E, Kessler J, Calabrese P. et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19 (02) 136-143 . doi:10.1002/gps.1042
21 Nasreddine ZS, Phillips NA, Bedirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (04) 695-699 . doi:10.1111/j.1532-5415.2005.53221.x
22 Nikolaus T, Bach M, Specht-Leible N. et al. The Timed Test of Money Counting: a short physical performance test for manual dexterity and cognitive capacity. Age Ageing 1995; 24 (03) 257-258
23 Nezu S, Okamoto N, Morikawa M. et al. Health-related quality of life (HRQOL) decreases independently of chronic conditions and geriatric syndromes in older adults with diabetes: the Fujiwara-kyo Study. J Epidemiol 2014; 24 (04) 259-266
24 Tancredi M, Rosengren A, Svensson AM. et al. Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med 2015; 373 (18) 1720-1732 . doi:10.1056/NEJMoa1504347
25 Gallagher P, Ryan C, Byrne S. et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46 (02) 72-83
26 Huang ES, Brown SES, Ewigman BG. et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007; 30 (10) 2478-2483 . doi:10.2337/dc07-0499
27 Laiteerapong N, Karter AJ, Liu JY. et al. Correlates of quality of life in older adults with diabetes: the diabetes & aging study. Diabetes Care 2011; 34 (08) 1749-1753 . doi:10.2337/dc10-2424
28 Gadamer HG. Über die Verborgenheit der Gesundheit. Aufsätze und Vorträge. Bd. 1135. Bibliothek Suhrkamp. Frankfurt am Main: Suhrkamp; 1993
29 Lown B, Drews H, Gottstein U. Die verlorene Kunst des Heilens. Anleitung zum Umdenken. Bd. 3574. Suhrkamp-Taschenbuch. 2.. Aufl. Frankfurt am Main: Suhrkamp; 2004
30 Rüter G. Individualität und Salutogenese in der Allgemeinmedizin. Ein Paradigmenwechsel für Versorgung, Forschung, Lehre und Politik?. Z Allg Med 2003; 79 (06) 278-282 . doi:10.1055/s-2003-41917
31 Landgraf R, Kellerer M, Fach E. et al. Praxisempfehlungen DDG/DGIM. Diabetologie und Stoffwechsel 2015; 10 (Suppl. 02) S140-S151 . doi:10.1055/s-0035-1553539
32 Qaseem A, Wilt TJ, Kansagara D. et al. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Ann Intern Med 2018; 168 (08) 569-576 . doi:10.7326/M17-0939
33 James PA, Oparil S, Carter BL. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311 (05) 507-520 . doi:10.1001/jama.2013.284427
34 American Diabetes Association. 10. Older Adults. Diabetes Care 2015; 38 (Suppl. 01) S67-S69 . doi:10.2337/dc15-S013
35 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes – Langfassung. Im Internet: 1. Auflage. Version 4. http://doi.org/10.6101/AZQ/000213 ; Stand: 06.07.2017
36 Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28 (12) 2948-2961
37 Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008; 57 (12) 3169-3176 . doi:10.2337/db08-1084
38 Meneilly GS, Cheung E, Tuokko H. Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrinol Metab 1994; 78 (06) 1341-1348 . doi:10.1210/jcem.78.6.8200936
39 Bremer JP, Jauch-Chara K, Hallschmid M. et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 2009; 32 (08) 1513-1517 . doi:10.2337/dc09-0114
40 Matyka K, Evans M, Lomas J. et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997; 20 (02) 135-141
41 Jaap AJ, Jones GC, McCrimmon RJ. et al. Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet Med 1998; 15 (05) 398-401 . doi:10.1002/(SICI)1096-9136(199805)15:5<398::AID-DIA595>3.0.CO;2-B
42 Bahrmann A, Worz E, Specht-Leible N. et al. Behandlungsqualität des Diabetes mellitus und Inzidenz schwerer Hypoglykamien in stationären und ambulanten Versorgungseinrichtungen: Heidelberger Diabetesstudie. Z Gerontol Geriatr 2015; 48 (03) 246-254 . doi:10.1007/s00391-014-0626-9
43 Budnitz DS, Lovegrove MC, Shehab N. et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365 (21) 2002-2012 . doi:10.1056/NEJMsa1103053
44 Pathak RD, Schroeder EB, Seaquist ER. et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011. Diabetes Care 2016; 39 (03) 363-370 . doi:10.2337/dc15-0858
45 Duckworth W, Abraira C, Moritz T. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360 (02) 129-139 . doi:10.1056/NEJMoa0808431
46 Bode BW, Schwartz S, Stubbs HA. et al. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 2005; 28 (10) 2361-2366
47 Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 2003; 5 (01) 19-26 . doi:10.1089/152091503763816427
48 Munshi MN, Segal AR, Suhl E. et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med 2011; 171 (04) 362-364 . doi:10.1001/archinternmed.2010.539
49 Holstein A, Patzer OM, Machalke K. et al. Substantial increase in incidence of severe hypoglycemia between 1997–2000 and 2007–2010: a German longitudinal population-based study. Diabetes Care 2012; 35 (05) 972-975 . doi:10.2337/dc11-1470
50 Zoungas S, Patel A, Chalmers J. et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363 (15) 1410-1418 . doi:10.1056/NEJMoa1003795
51 Punthakee Z, Miller ME, Launer LJ. et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012; 35 (04) 787-793 . doi:10.2337/dc11-1855
52 Gais S, Born J, Peters A. et al. Hypoglycemia counterregulation during sleep. Sleep 2003; 26 (01) 55-59
53 Chico A, Vidal-Rios P, Subira M. et al. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003; 26 (04) 1153-1157
54 Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010; 33 (06) 1389-1394 . doi:10.2337/dc09-2082
55 Chow E, Bernjak A, Williams S. et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 2014; 63 (05) 1738-1747 . doi:10.2337/db13-0468
56 Saremi A, Bahn GD, Reaven PD. A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care 2016; 39 (03) 448-454 . doi:10.2337/dc15-2107
57 Goto A, Arah OA, Goto M. et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533 . doi:10.1136/bmj.f4533
58 Whitmer RA, Karter AJ, Yaffe K. et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301 (15) 1565-1572 . doi:10.1001/jama.2009.460
59 Yaffe K, Falvey CM, Hamilton N. et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013; 173 (14) 1300-1306 . doi:10.1001/jamainternmed.2013.6176
60 Lin CH, Sheu WHH. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med 2013; 273 (01) 102-110 . doi:10.1111/joim.12000
61 Aung PP, Strachan MWJ, Frier BM. et al. Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabet Med 2012; 29 (03) 328-336 . doi:10.1111/j.1464-5491.2011.03505.x
62 Feinkohl I, Aung PP, Keller M. et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care 2014; 37 (02) 507-515 . doi:10.2337/dc13-1384
63 Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005; 48 (07) 1292-1299 . doi:10.1007/s00125-005-1786-3
64 Puar TH, Khoo JJ, Cho LW. et al. Association between glycemic control and hip fracture. J Am Geriatr Soc 2012; 60 (08) 1493-1497 . doi:10.1111/j.1532-5415.2012.04052.x
65 Bahrmann A, Abel A, Zeyfang A. et al. Psychological insulin resistance in geriatric patients with diabetes mellitus. Patient Educ Couns 2014; 94 (03) 417-422 . doi:10.1016/j.pec.2013.11.010
66 Marouf E, Sinclair AJ. Use of short-acting insulin aspart in managing older people with diabetes. Clin Interv Aging 2009; 4: 187-190
67 Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2008; 81 (02) 184-189 . doi:10.1016/j.diabres.2008.04.007
68 Ritzel R, Roussel R, Bolli GB. et al. Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Diabetes Obes Metab 2015; 17 (09) 859-867 . doi:10.1111/dom.12485
69 Braun AK, Kubiak T, Kuntsche J. et al. SGS: a structured treatment and teaching programme for older patients with diabetes mellitus – a prospective randomised controlled multi-centre trial. Age Ageing 2009; 38 (04) 390-396 . doi:10.1093/ageing/afp056
70 Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31 (07) 1281-1357 . doi:10.1097/01.hjh.0000431740.32696.cc
71 Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34 (28) 2159-2219 . doi:10.1093/eurheartj/eht151
72 Zhang Y, Zhang X, Liu L. et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. Eur Heart J 2011; 32 (12) 1500-1508 . doi:10.1093/eurheartj/ehr039
73 Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: Systematic review and meta-analyses. BMJ 2016; 352: i717
74 Beckett NS, Peters R, Fletcher AE. et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358 (18) 1887-1898 . doi:10.1056/NEJMoa0801369
75 Kjeldsen SE, Stenehjem A, Os I. et al. Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets. Blood Press 2016; 25 (06) 333-336 . doi:10.1080/08037051.2016.1236329
76 Mossello E, Pieraccioli M, Nesti N. et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 2015; 175 (04) 578-585 . doi:10.1001/jamainternmed.2014.8164
77 Baigent C, Blackwell L, Emberson J. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681 . doi:10.1016/S0140-6736(10)61350-5
78 Ryden L, Grant PJ, Anker SD. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34 (39) 3035-3087 . doi:10.1093/eurheartj/eht108
79 Reiner Z, Catapano AL, de Backer G. et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32 (14) 1769-1818 . doi:10.1093/eurheartj/ehr158
80 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Chronische KHK – Langfassung, 4. Auflage. Version 1. Im Internet: http://www.leitlinien.de/nvl/khk ; Stand: 17.12.2017
81 Thompson PD, Panza G, Zaleski A. et al. Statin-Associated Side Effects. J Am Coll Cardiol 2016; 67 (20) 2395-2410 . doi:10.1016/j.jacc.2016.02.071
82 Ganga HV, Slim HB, Thompson PD. A systematic review of statin-induced muscle problems in clinical trials. Am Heart J 2014; 168 (01) 6-15 . doi:10.1016/j.ahj.2014.03.019
83 Lipska KJ, Krumholz H, Soones T. et al. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. JAMA 2016; 315 (10) 1034-1045 . doi:10.1001/jama.2016.0299
84 Freeman J. Hot Topics in Primary Care: Considerations in the Selection of Antihyperglycemic Therapy for Older Patients With Type 2 Diabetes Mellitus: A Focus on Newer Therapies. J Fam Pract 2015; 64 (Suppl. 12) S59-S66
85 Peron EP, Ogbonna KC, Donohoe KL. Antidiabetic medications and polypharmacy. Clin Geriatr Med 2015; 31 (01) 17-27, vii . doi:10.1016/j.cger.2014.08.017
86 American Diabetes Association. Standards of Medical Care in Diabetes – 2016. Diabetes Care 2016; 39 (01) S52-S59
87 Mathur S, Zammitt NN, Frier BM. Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?. Drug Saf 2015; 38 (01) 17-32 . doi:10.1007/s40264-014-0247-7
88 American Geriatrics Society. Guidelines for Improving the Care of the Older Adult with Diabetes Mellitus: 2013 Update. Im Internet: https://geriatricscareonline.org/ProductAbstract/guidelines-for-improving-the-care-of-the-older-adult-with-diabetes-mellitus-2013-update-and-supplemental-information/CL008 ; Stand: 24.06.2017
89 Leitliniengruppe Hessen, Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin, PMV forschungsgruppe, Ärztliches Zentrum für Qualität in der Medizin. Hausärztliche Leitlinie Multimedikation. Empfehlungen zum Umgang mit Multimedikation bei Erwachsenen und geriatrischen Patienten. Version 1.09. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/053-043l_S2e_Multimedikation_2014-05.pdf ; Stand: 25.05.2017
90 Haefeli WE. Hilfsmittel zur Arzneimittel-Anwendung & -Sicherheit. Dosierung bei Niereninsuffizienz. http://www.dosing.de/nierebck.php Im Internet: ; Stand: 24.06.2017
91 Fletcher A. Multidimensional assessment of elderly people in the community. Br Med Bull 1998; 54 (04) 945-960
92 Sommeregger U. Das multidimensionale geriatrische Assessment. Z Gerontol Geriatr 2013; 46 (03) 277-285 ; quiz 285–286. doi:10.1007/s00391-013-0473-0
93 Zeyfang A. Neue Diabetes-Leitlinie für geriatrische Patienten. Die Besonderheiten bei Senioren auf einen Blick. MMW Fortschr Med 2005; 147 (07) 37-39–40
94 Watson YI, Arfken CL, Birge SJ. Clock completion: an objective screening test for dementia. J Am Geriatr Soc 1993; 41 (11) 1235-1240
95 Kessler J, Calabrese P, Kalbe E. et al. DemTect: A new screening method to support diagnosis of dementia. Psycho 2000; 26: 343-347
96 Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12 (03) 189-198
97 Yang Y, Hu X, Zhang Q. et al. Diabetes mellitus and risk of falls in older adults: a systematic review and meta-analysis. Age Ageing 2016; 45 (06) 761-767 . doi:10.1093/ageing/afw140
98 Park SW, Goodpaster BH, Lee JS. et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009; 32 (11) 1993-1997 . doi:10.2337/dc09-0264
99 Park SH. Tools for assessing fall risk in the elderly: A systematic review and meta-analysis. Aging Clin Exp Res 2017;
100 Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39 (02) 142-148
101 Guralnik JM, Simonsick EM, Ferrucci L. et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49 (02) M85-M94
102 Guigoz Y, Vellas B, Garry PJ. Mini Nutritional Assessment: a practical assessment tool for grading the nutritional state of elderly patients. Facts Res Gerontol 1994: 12-13
103 Rubenstein LZ, Harker JO, Salvà A. et al. Screening for undernutrition in geriatric practice: Developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 2001; 56 (06) M366-M372
104 Heuft G. Formen und Erscheinungsbilder der depressiven Syndrome. In: Hirsch RD. Hrsg Altern und Depressivität. Bern: Hans Huber; 1992: 29-43
105 Yesavage JA, Brink TL, Rose TL. et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982; 17 (01) 37-49
106 Gonzalez JS, Peyrot M, McCarl LA. et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 2008; 31 (12) 2398-2403 . doi:10.2337/dc08-1341
107 Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9 (03) 179-186
108 Nikolaus T, Bach M, Oster P. et al. The Timed Test of Money Counting: a simple method of recognizing geriatric patients at risk for increased health care. Aging (Milano) 1995; 7 (03) 179-183
109 Nikolaus T, Specht-Leible N, Bach M. et al. Soziale Aspekte bei Diagnostik und Therapie hochbetagter Patienten. Erste Erfahrungen mit einem neu entwickelten Fragebogen im Rahmen des geriatrischen Assessment. Z Gerontol 1994; 27 (04) 240-245
110 Maffi P, Secchi A. The Burden of Diabetes: Emerging Data. Dev Ophthalmol 2017; 60: 1-5 . doi:10.1159/000459641
111 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Prävention und Therapie von Netzhautkomplikationen bei Diabetes – Langfassung, 2. Auflage. Version 2. Im Internet: http://www.netzhautkomplikationen.versorgungsleitlinien.de ; Stand: 24.06.2017
112 Escobar C, Blanes I, Ruiz A. et al. Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes. Eur J Intern Med 2011; 22 (03) 275-281 . doi:10.1016/j.ejim.2011.02.001
113 Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005; 28 (02) 461-471
114 Schaper NC, Andros G, Apelqvist J. et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2012; 28 (Suppl. 01) 218-224 . doi:10.1002/dmrr.2255
115 La Manna G, Pancaldi LG, Capecchi A. et al. Risk for contrast nephropathy in patients undergoing coronarography. Artif Organs 2010; 34 (06) E193-E199 . doi:10.1111/j.1525-1594.2009.00984.x
116 Bachorzewska-Gajewska H, Malyszko J, Malyszko JS. et al. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention. Nephrology (Carlton) 2006; 11 (06) 549-554 . doi:10.1111/j.1440-1797.2006.00709.x
117 Hinchliffe RJ, Andros G, Apelqvist J. et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev 2012; 28 (Suppl. 01) 179-217 . doi:10.1002/dmrr.2249
118 Pataky Z, Vischer U. Diabetic foot disease in the elderly. Diabetes Metab 2007; 33 (Suppl. 01) S56-S65
119 de Leur K, van Zeeland MLP, Ho GH. et al. Treatment for critical lower limb ischemia in elderly patients. World J Surg 2012; 36 (12) 2937-2943 . doi:10.1007/s00268-012-1758-y
120 Carmona GA, Hoffmeyer P, Herrmann FR. et al. Major lower limb amputations in the elderly observed over ten years: the role of diabetes and peripheral arterial disease. Diabetes Metab 2005; 31 (05) 449-454
121 Morbach S, Müller E, Reike H. et al. Diabetisches Fußsyndrom. Diabetologie und Stoffwechsel 2017; 12 (Suppl. 02) S181-S189 . doi:10.1055/s-0043-115979
122 McCue JD. Antibiotic use in the elderly: issues and nonissues. Clin Infect Dis 1999; 28 (04) 750-752 . doi:10.1086/515210
123 Green P, Woglom AE, Genereux P. et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv 2012; 5 (09) 974-981 . doi:10.1016/j.jcin.2012.06.011
124 Vetrano DL, Landi F, Volpato S. et al. Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. J Gerontol A Biol Sci Med Sci 2014; 69 (09) 1154-1161 . doi:10.1093/gerona/glu034
125 Waaijman R, Keukenkamp R, de Haart M. et al. Adherence to wearing prescription custom-made footwear in patients with diabetes at high risk for plantar foot ulceration. Diabetes Care 2013; 36 (06) 1613-1618 . doi:10.2337/dc12-1330
126 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Typ-2-Diabetes Präventions- und Behandlungsstrategien für Fußkomplikationen, 1. Auflage. Version 2.8. Im Internet: http://www.leitlinien.de/mdb/downloads/nvl/diabetes-mellitus/archiv/fusskomplikationen/dm2-fuss-lang-2.8.pdf ; Stand: 25.05.2017
127 Moran AE, Forouzanfar MH, Roth GA. et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation 2014; 129 (14) 1483-1492 . doi:10.1161/CIRCULATIONAHA.113.004042
128 Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34 (38) 2949-3003 . doi:10.1093/eurheartj/eht296
129 Bypass Angioplasty Revascularization Investigation. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation 1997; 96 (06) 1761-1769
130 Hee L, Mussap CJ, Yang L. et al. Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease. Am J Cardiol 2012; 110 (05) 643-648 . doi:10.1016/j.amjcard.2012.04.043
131 Farkouh ME, Domanski M, Sleeper LA. et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367 (25) 2375-2384 . doi:10.1056/NEJMoa1211585
132 Windecker S, Kolh P, Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35 (37) 2541-2619 . doi:10.1093/eurheartj/ehu278
133 Hakeem A, Garg N, Bhatti S. et al. Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data. J Am Heart Assoc 2013; 2 (04) e000354 . doi:10.1161/JAHA.113.000354
134 Verma S, Farkouh ME, Yanagawa B. et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol 2013; 1 (04) 317-328 . doi:10.1016/S2213-8587(13)70089-5
135 Nashef SAM, Roques F, Sharples LD. et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41 (04) 734-744 ; discussion 744-745. doi:10.1093/ejcts/ezs043
136 Shan L, Saxena A, McMahon R. et al. Coronary artery bypass graft surgery in the elderly: a review of postoperative quality of life. Circulation 2013; 128 (21) 2333-2343 . doi:10.1161/CIRCULATIONAHA.112.000729
137 Brieger D, Eagle KA, Goodman SG. et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest 2004; 126 (02) 461-469 . doi:10.1378/chest.126.2.461
138 Steg PG, James SK, Atar D. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33 (20) 2569-2619 . doi:10.1093/eurheartj/ehs215
139 Rich MW, Chyun DA, Skolnick AH. et al. Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society. Circulation 2016; 133 (21) 2103-2122 . doi:10.1161/CIR.0000000000000380
140 Patel MR, Calhoon JH, Dehmer GJ. et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 69 (05) 570-591 . doi:10.1016/j.jacc.2016.10.034
141 Alexander KP, Newby LK, Armstrong PW. et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115 (19) 2570-2589 . doi:10.1161/CIRCULATIONAHA.107.182616
142 Dziewierz A, Siudak Z, Rakowski T. et al. Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty. J Thromb Thrombolysis 2012; 34 (02) 214-221 . doi:10.1007/s11239-012-0713-y
143 Nauta ST, Deckers JW, Akkerhuis KM. et al. Age-dependent care and long-term (20 year) mortality of 14,434 myocardial infarction patients: changes from 1985 to 2008. Int J Cardiol 2013; 167 (03) 693-697 . doi:10.1016/j.ijcard.2012.03.064
144 Roffi M, Patrono C, Collet JP. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37 (03) 267-315 . doi:10.1093/eurheartj/ehv320
145 Bahrmann P, Christ M, Bahrmann A. et al. A 3-hour diagnostic algorithm for non-ST-elevation myocardial infarction using high-sensitivity cardiac troponin T in unselected older patients presenting to the emergency department. J Am Med Dir Assoc 2013; 14 (06) 409-416 . doi:10.1016/j.jamda.2012.12.005
146 Alexander KP, Newby LK, Cannon CP. et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115 (19) 2549-2569 . doi:10.1161/CIRCULATIONAHA.107.182615
147 Ekerstad N, Swahn E, Janzon M. et al. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 2011; 124 (22) 2397-2404 . doi:10.1161/CIRCULATIONAHA.111.025452
148 Ringleb PA, Hamann GF, Röther J. et al. Akuttherapie des ischämischen Schlaganfalls – Rekanalisierende Therapie (Ergänzung 2015). Leitlinien für Diagnostik und Therapie in der Neurologie. Im Internet: http://www.dsg-info.de/images/stories/DSG/PDF/Leitlinien/030140_LL_akuter-ischaemischer-schlaganfall_final.pdf ; Stand: 12.06.2017
149 Mishra NK, Ahmed N, Davalos A. et al. Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology 2011; 77 (21) 1866-1872 . doi:10.1212/WNL.0b013e318238ee42
150 Ringleb PA, Bousser MG, Ford G. Ischaemic Stroke and Transient Ischaemic Attack. In: Gilhus NE, Brainin M, Barnes MP. eds. European handbook of neurological management: Volume 1. 2nd. ed. Chichester, West Sussex, UK: Wiley-Blackwell; 2010
151 Veltkamp R. 22 Akuttherapie des ischämischen Schlaganfalls. In: Diener HC. Hrsg Leitlinien für Diagnostik und Therapie in der Neurologie. Herausgegeben von der Kommission quot;Leitlinienquot; der DGN. 5.. Aufl. s.l. Georg Thieme Verlag KG; 2012: 307-309 . doi:10.1055/b-0034-37805
152 Gray CS, Hildreth AJ, Sandercock PA. et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007; 6 (05) 397-406 . doi:10.1016/S1474-4422(07)70080-7
153 Kronsbein P, Jorgens V, Muhlhauser I. et al. Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet 1988; 2: 1407-1411
154 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Diabetes – Strukturierte Schulungsprogramme – Kurzfassung, 1. Auflage. Version 4. Im Internet: http://dx.doi.org/10.6101/AZQ/000317 ; Stand: 25.05.2017
155 Cigolle CT, Lee PG, Langa KM. et al. Geriatric conditions develop in middle-aged adults with diabetes. J Gen Intern Med 2011; 26 (03) 272-279 . doi:10.1007/s11606-010-1510-y
156 Oliveira RA, Tostes M, Queiroz VA. et al. Insulin mediated improvement in glycemic control in elderly with type 2 diabetes mellitus can improve depressive symptoms and does not seem to impair health-related quality of life. Diabetol Metab Syndr 2015; 7: 55 . doi:10.1186/s13098-015-0052-1
157 Pepersack T. Nutritional problems in the elderly. Acta Clin Belg 2009; 64 (02) 85-91 . doi:10.1179/acb.2009.017
158 Thongsai S, Youjaiyen M. The long-term impact of education on diabetes for older people: a systematic review. Glob J Health Sci 2013; 5 (06) 30-39 . doi:10.5539/gjhs.v5n6p30
159 Dunning T, Sinclair A. International Diabetes Federation. et al. The IDF global guideline for managing older people with type 2 diabetes: Implications for nurses. Journal of Diabetes Nursing 2014; 18 (04) 145-150
160 Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 2000; 50 (03) 203-212
161 Sinclair AJ. Special Considerations in Older Adults With Diabetes. Meeting the Challenge. Diabetes Spectrum 2006; 19 (04) 229-233 . doi:10.2337/diaspect.19.4.229
162 Silliman RA, Bhatti S, Khan A. et al. The care of older persons with diabetes mellitus: families and primary care physicians. J Am Geriatr Soc 1996; 44 (11) 1314-1321
163 Deutsche Diabetes Gesellschaft. AG Diabetes und Migranten der DDG. Im Internet: http://migration.deutsche-diabetes-gesellschaft.de/ueber-uns.html ; Stand: 21.12.2017
164 Zeyfang A, Feucht I, Fetzer G. et al. Eine strukturierte geriatrische Diabetiker-Schulung (SGS) ist sinnvoll. Diabetes und Stoffwechsel 2001; 10: 203-207
165 Forjuoh SN, Huber C, Bolin JN. et al. Provision of counseling on diabetes self-management: are there any age disparities?. Patient Educ Couns 2011; 85 (02) 133-139 . doi:10.1016/j.pec.2010.08.004
166 Weinstock RS, Teresi JA, Goland R. et al. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study. Diabetes Care 2011; 34 (02) 274-279 . doi:10.2337/dc10-1346
167 Mayne D, Stout NR, Aspray TJ. Diabetes, falls and fractures. Age Ageing 2010; 39 (05) 522-525 . doi:10.1093/ageing/afq081
168 Morrison S, Colberg SR, Mariano M. et al. Balance training reduces falls risk in older individuals with type 2 diabetes. Diabetes Care 2010; 33 (04) 748-750 . doi:10.2337/dc09-1699
169 Tilling LM, Darawil K, Britton M. Falls as a complication of diabetes mellitus in older people. J Diabetes Complications 2006; 20 (03) 158-162 . doi:10.1016/j.jdiacomp.2005.06.004
170 Schwartz AV, Vittinghoff E, Sellmeyer DE. et al. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008; 31 (03) 391-396 . doi:10.2337/dc07-1152
171 Huang ES, Karter AJ, Danielson KK. et al. The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study. J Gen Intern Med 2010; 25 (02) 141-146 . doi:10.1007/s11606-009-1179-2
172 Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc 2007; 55 (12) 2041-2044 . doi:10.1111/j.1532-5415.2007.01430.x
173 Macgilchrist C, Paul L, Ellis BM. et al. Lower-limb risk factors for falls in people with diabetes mellitus. Diabet Med 2010; 27 (02) 162-168 . doi:10.1111/j.1464-5491.2009.02914.x
174 Allet L, Armand S, de Bie RA. et al. The gait and balance of patients with diabetes can be improved: a randomised controlled trial. Diabetologia 2010; 53 (03) 458-466 . doi:10.1007/s00125-009-1592-4
175 Salsabili H, Bahrpeyma F, Forogh B. et al. Dynamic stability training improves standing balance control in neuropathic patients with type 2 diabetes. J Rehabil Res Dev 2011; 48 (07) 775-786
176 Park SW, Goodpaster BH, Strotmeyer ES. et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 2006; 55 (06) 1813-1818 . doi:10.2337/db05-1183
177 Leenders M, Verdijk LB, van der Hoeven L. et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013; 14 (08) 585-592 . doi:10.1016/j.jamda.2013.02.006
178 Villareal DT, Chode S, Parimi N. et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 2011; 364 (13) 1218-1229 . doi:10.1056/NEJMoa1008234
179 Buman MP, Hekler EB, Haskell WL. et al. Objective light-intensity physical activity associations with rated health in older adults. Am J Epidemiol 2010; 172 (10) 1155-1165 . doi:10.1093/aje/kwq249
180 Hupin D, Roche F, Gremeaux V. et al. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged /=60 years: a systematic review and meta-analysis. Br J Sports Med 2015; 49 (19) 1262-1267 . doi:10.1136/bjsports-2014-094306
181 Medizinischer Dienst des Spitzenverbandes der Krankenkassen. Grundsatzstellungsnahme: Essen und Trinken im Alter. Ernährung und Flüssigkeitsversorgung älterer Menschen. Im Internet: http://www.mdk.de/media/pdf/Grundsatzstellungnahme_EssenTrinken_im_Alter_Mai_2014.pdf ; Stand: 25.06.2017
182 Volkert D, Bauer J, Frühwald T. et al. Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES, der AKE und der DGG. Aktuel Ernahrungsmed 2013; 38 (03) e1-e48 . doi:10.1055/s-0033-1343169
183 Thinggaard M, Jacobsen R, Jeune B. et al. Is the relationship between BMI and mortality increasingly U-shaped with advancing age? A 10-year follow-up of persons aged 70-95 years. J Gerontol A Biol Sci Med Sci 2010; 65 (05) 526-531 . doi:10.1093/gerona/glp214
184 Wedick NM, Barrett-Connor E, Knoke JD. et al. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. J Am Geriatr Soc 2002; 50 (11) 1810-1815
185 Wöstmann B, Michel K, Brinkert B. et al. Influence of denture improvement on the nutritional status and quality of life of geriatric patients. J Dent 2008; 36 (10) 816-821 . doi:10.1016/j.jdent.2008.05.017
186 Deutsche Diabetes Gesellschaft. Ernährungsempfehlungen zur Behandlung des Diabetes mellitus – Empfehlungen zur Proteinzufuhr. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/057-025l_S3_Diabetes_mellitus_Empfehlungen_Proteinzufuhr_2015-10.pdf ; Stand: 11.12.2017
187 Schloot NC, Haupt A, Schütt M. et al. Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?. Diabetes Metab Res Rev 2016; 32 (03) 316-324 . doi:10.1002/dmrr.2722
188 Hasslacher C, Wittmann W. Schwere Hypoglykämien bei Diabetikern mit eingeschränkter Nierenfunktion. Dtsch Med Wochenschr 2003; 128 (06) 253-256 . doi:10.1055/s-2003-37077
189 Krobot KJ, Ferrante SA, Davies MJ. et al. Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value. Curr Med Res Opin 2012; 28 (08) 1281-1287 . doi:10.1185/03007995.2012.703134
190 Zeyfang A, Bahrmann A, Wernecke J. Diabetes mellitus im Alter. Diabetologie und Stoffwechsel 2015; 10 (Suppl. 02) S192-S198 . doi:10.1055/s-0035-1553883
191 Marso SP, Daniels GH, Brown-Frandsen K. et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2016; 375 (04) 311-322 . doi:10.1056/NEJMoa1603827
192 Eng C, Kramer CK, Zinman B. et al. Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. Lancet 2014; 384: 2228-2234 . doi:10.1016/S0140-6736(14)61335-0
193 Pernicova I, Korbonits M. Metformin--mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol 2014; 10 (03) 143-156 . doi:10.1038/nrendo.2013.256
194 Ferrannini E. The target of metformin in type 2 diabetes. N Engl J Med 2014; 371 (16) 1547-1548 . doi:10.1056/NEJMcibr1409796
195 Madiraju AK, Erion DM, Rahimi Y. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 2014; 510: 542-546 . doi:10.1038/nature13270
196 Inzucchi SE, Lipska KJ, Mayo H. et al. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 2014; 312 (24) 2668-2675 . doi:10.1001/jama.2014.15298
197 Takeda Pharma GmbH. Leicht erhöhtes Risiko von Blasenkarzinomen unter der Einnahme von Pioglitazon-haltigen Arzneimitteln (actos©, Competact© und Tandemact©) (11.12.2017). Im Internet: http://www.akdae.de/Arzneimittelsicherheit/RHB/Archiv/2011/20110729.pdf
198 Neal B, Perkovic V, Mahaffey KW. et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med 2017; 377 (07) 644-657 . doi:10.1056/NEJMoa1611925
199 D’Elia JA, Segal AR, Bayliss GP. et al. Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: A review of US FDA data and possible conclusions. Int J Nephrol Renovasc Dis 2017; 10: 153-158 . doi:10.2147/IJNRD.S135899
200 Zinman B, Wanner C, Lachin JM. et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 2015; 373 (22) 2117-2128 . doi:10.1056/NEJMoa1504720
201 Fitchett D, Zinman B, Wanner C. et al. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: Results of the EMPA-REG OUTCOME® trial. Eur Heart J 2016; 37 (19) 1526-1534 . doi:10.1093/eurheartj/ehv728
202 U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR). Im Internet: https://www.fda.gov/Drugs/DrugSafety/ucm505860.htm ; Stand: 12.11.2017
203 Calabro P, von Eynatten M, Wanner C. Effect of Empagliflozin on Nephropathy in Subgroups by Age: Results from EMPA-REG OUTCOME®. 2nd Cardiovascular Outcome Trial Summit of the Diabetes and Cardiovascular Disease Study Group of the European Association for the Study of Diabetes, Munich, 20 – 21 Oct 2016 (Poster). 2016
204 Monteiro P, Schaper N, Clark D. Effect of Empagliflozin on Heart Failure Outcomes in Subgroups by Age: Results from EMPA-REG OUTCOME® 1116-P; American Diabetes Association 76th Scientific Sessions, 10–14 June 2016, New Orleans, Louisiana, USA. 2016
205 Ridderstråle M, Toural E, Fitchett D. Effect of Empagliflozin on Cardiovascular Death in Subgroups by Age: Results from EMPA-REG OUTCOME® 1109-P; American Diabetes Association 76th Scientific Sessions, 10–14 June 2016, New Orle-ans, Louisiana, USA. 2016
206 Braun A, Sämann A, Kubiak T. et al. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus. Patient Educ Couns 2008; 73 (01) 50-59 . doi:10.1016/j.pec.2008.05.005
207 Bahrmann A, Abel A, Specht-Leible N. et al. Behandlungsqualitat bei geriatrischen Patienten mit Diabetes mellitus in verschiedenen hauslichen Versorgungsstrukturen. Z Gerontol Geriatr 2010; 43 (06) 386-392 . doi:10.1007/s00391-010-0104-y
208 Rillig A, Müller UA, Braun A. et al. Quality of life in patients with type 1 and insulin treated type 2 diabetes mellitus in a general population. Diab Stoffw 2003; 12: 95-104
209 Du YF, Ou HY, Beverly EA. et al. Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options. Clin Interv Aging 2014; 9: 1963-1980 . doi:10.2147/CIA.S53482
210 Leitliniengruppe Hessen. Hausärztliche Leitlinie Diabetes mellitus Typ 2. Therapie des Diabetes mellitus Typ 2. Version 3.00. Im Internet: www.pmvforschungsgruppe.de/pdf/03_publikationen/diabetes_ll.pdf ; Stand: 19.10.2017
211 Horvath K, Jeitler K, Berghold A. et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007; 2: CD005613 . doi:10.1002/14651858.CD005613.pub3
212 Cigolle CT, Blaum CS, Halter JB. Diabetes and cardiovascular disease prevention in older adults. Clin Geriatr Med 2009; 25 (04) 607-641, vii-viii . doi:10.1016/j.cger.2009.09.001
213 Kirkman MS, Briscoe VJ, Clark N. et al. Diabetes in older adults. Diabetes Care 2012; 35 (12) 2650-2664 . doi:10.2337/dc12-1801
214 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265 (24) 3255-3264
215 MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412
216 Amery A, Birkenhager W, Brixko P. et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-1354
217 Dahlof B, Lindholm LH, Hansson L. et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285
218 Hansson L, Lindholm LH, Ekbom T. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354: 1751-1756
219 Liu L, Wang JG, Gong L. et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998; 16 (12) 1823-1829
220 Staessen JA, Fagard R, Thijs L. et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764
221 Lithell H, Hansson L, Skoog I. et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21 (05) 875-886 . doi:10.1097/01.hjh.0000059028.82022.89
222 Wiysonge CS, Bradley HA, Volmink J. et al. Beta-blockers for hypertension. Cochrane Database Syst Rev 2017; 1: CD002003 . doi:10.1002/14651858.CD002003.pub5
223 Turnbull F, Neal B, Ninomiya T. et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121-1123 . doi:10.1136/bmj.39548.738368.BE
224 de Berardis G, Sacco M, Strippoli GFM. et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: Meta-analysis of randomised controlled trials. BMJ 2009; 339 (02) b4531 . doi:10.1136/bmj.b4531
225 Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106 . doi:10.1136/bmj.308.6921.81
226 Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86 . doi:10.1136/bmj.324.7329.71
227 Verband der Diabetesberatungs- und Schulungsberufe. Leitfaden zur Blutzucker-Selbstkontrolle, 1. Auflage. Im Internet: https://www.vdbd.de/Downloads/Blutzucker-Selbstkontrolle-Stand1142014.pdf ; Stand: 24.06.2017
228 Deutsche Diabetes Gesellschaft. S3-Leitlinie Therapie des Typ-1-Diabetes, 2. Auflage. Im Internet: https://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Leitlinien/Evidenzbasierte_Leitlinien/2018/S3-LL-Therapie-Typ-1-Diabetes-Auflage-2-Langfassung-09042018.pdf ; Stand: 14.05.2018
229 Brown SA. Studies of educational interventions and outcomes in diabetic adults: A meta-analysis revisited. Patient Educ Couns 1990; 16 (03) 189-215
230 Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen. Gutachten 2007. Kooperation und Verantwortung – Voraussetzungen einer zielorientierten Gesundheitsversorgung. Im Internet: http://www.svr-gesundheit.de/index.php?id=15 ; Stand: 25.06.2017
231 Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen. Sondergutachten 2009. Koordination und Integration – Gesundheitsversorgung in einer Gesellschaft des längeren Lebens. Im Internet: http://www.svr-gesundheit.de/index.php?id=14 ; Stand: 25.06.2017
232 Morbach S, Uebel T. Das diabetische Fußsyndrom und seine sektorübergreifende und interdisziplinäre Versorgung – das Modul „Prävention und Behandlungsstrategien für Fußkomplikationen” der Versorgungsleitlinie Diabetes. Z Allg Med 2007; 83 (08) 328-338 . doi:10.1055/s-2007-984356
233 Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen. Sondergutachten 2012. Wettbewerb an der Schnittstelle zwischen ambulanter und stationärer Gesundheitsversorgung. Im Internet: http://www.svr-gesundheit.de/index.php?id=378 ; Stand: 25.06.2017
234 Schubert I, Siegel A, Koster I. et al. Evaluation der populationsbezogenen „Integrierten Versorgung Gesundes Kinzigtal“ (IVGK). Ergebnisse zur Versorgungsqualitat auf der Basis von Routinedaten. Z Evid Fortbild Qual Gesundhwes 2016; 117: 27-37 . doi:10.1016/j.zefq.2016.06.003
235 Rümenapf G, Morbach S, Boettrich J. et al. Intersektorale Versorgung von Patienten mit diabetischem Fußsyndrom. Diabetologe 2015; 11 (01) 22-27 . doi:10.1007/s11428-014-1321-6
236 Grundke S, Klement A. Betreuungsprobleme älterer insulinpflichtiger Diabetiker. In: Detka C. Hrsg. Qualitative Gesundheitsforschung. Beispiele aus der interdisziplinären Forschungspraxis. ZBBS-Buchreihe. Leverkusen-Opladen: Barbara Budrich; 2016
237 Grundke S, Klement A. Pflegebedürftigkeit. Beratung – Betreuung – Zusammenarbeit. Praxishilfen: Praktische Geriatrie. Mainz: Kirchheim Verlag; 2016
238 Grundke S, Klement A. Pflegebedürftigkeit. Beratung – Betreuung – Zusammenarbeit. Praxishilfen praktische Geriatrie, Band 5. Mainz: Kirchheim; 2015
239 Gemeinsamer Bundesausschuss. Richtlinie Häusliche Krankenpflege-Richtlinie,, § 92 SGB V. Stand: 18. Juli 2013. Im Internet: https://www.g-ba.de/downloads/62-492-764/HKP-RL_2013-02-21_und_2013_07_18.pdf ; Stand: 017-05-25
240 Cardenas-Valladolid J, Salinero-Fort MA, Gomez-Campelo P. et al. Effectiveness of standardized Nursing Care Plans in health outcomes in patients with type 2 Diabetes Mellitus: a two-year prospective follow-up study. PLoS One 2012; 7 (08) e43870 . doi:10.1371/journal.pone.0043870
241 Sinclair A, Morley JE, Rodriguez-Manas L. et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012; 13 (06) 497-502 . doi:10.1016/j.jamda.2012.04.012
242 Sinclair A, Dunning T, Rodriguez-Manas L. Diabetes in older people: new insights and remaining challenges. Lancet Diabetes Endocrinol 2015; 3 (04) 275-285 . doi:10.1016/S2213-8587(14)70176-7
243 Bentley A. Case management and long-term conditions: the evolution of community matrons. Br J Community Nurs 2014; 19 (07) 340-342-345 . doi:10.12968/bjcn.2014.19.7.340
244 Büscher A, Blumenberg P, Krebs M. Deutsches Netzwerk für Qualitätsentwicklung in der Pflege. et al. Expertenstandard Pflege von Menschen mit chronischen Wunden. Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege. Osnabrück: Hochschule Osnabrück; 2015
245 Munshi MN, Florez H, Huang ES. et al. Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care 2016; 39 (02) 308-318 . doi:10.2337/dc15-2512
246 Wakefield PL, Wilson MA. Enhancing nurses’ knowledge regarding the complex care of hospitalized patients on insulin. J Nurses Prof Dev 2014; 30 (04) 174-180 . doi:10.1097/NND.0000000000000037
247 Morbach S, Müller E, Reike H. et al. Diabetisches Fußsyndrom. In: Landgraf R, Kellerer M, Fach E. et al. Hrsg. Praxisempfehlungen DDG/DGIM Therapie des Typ-2-Diabetes. S02. 10.. Aufl. 2015: 172-180
248 Lincoln NB, Jeffcoate WJ, Ince P. et al. Validation of a new measure of protective footcare behaviour. The Nottingham Assessment of Functional Footcare (NAFF). Pract Diab Int 2007; 24 (04) 207-211 . doi:10.1002/pdi.1099
249 Hareendran A, Doll H, Wild DJ. et al. The venous leg ulcer quality of life (VLU-QoL) questionnaire: development and psychometric validation. Wound Repair Regen 2007; 15 (04) 465-473 . doi:10.1111/j.1524-475X.2007.00253.x
250 Vosseler A. Kleidung und Schuhe. In: Hodeck K, Bahrmann A. Hrsg. Pflegewissen Diabetes. Praxistipps für die Betreuung älterer Diabetes-Patienten. Berlin: Springer Berlin; 2014: 237ff
251 Hodeck K. Förderung des pflegebedürftigen Diabetes-Patienten. In: Hodeck K, Bahrmann A. Hrsg. Pflegewissen Diabetes. Praxistipps für die Betreuung älterer Diabetes-Patienten. Berlin: Springer Berlin; 2014: 154-163
252 Augustin M, Herberger K, Rustenbach SJ. et al. Quality of life evaluation in wounds: validation of the Freiburg Life Quality Assessment-wound module, a disease-specific instrument. Int Wound J 2010; 7 (06) 493-501 . doi:10.1111/j.1742-481X.2010.00732.x
253 Blome C, Baade K, Debus ES. et al. The "Wound-QoL": a short questionnaire measuring quality of life in patients with chronic wounds based on three established disease-specific instruments. Wound Repair Regen 2014; 22 (04) 504-514 . doi:10.1111/wrr.12193
254 Büscher A. Deutsches Netzwerk für Qualitätsentwicklung in der Pflege. Expertenstandard Schmerzmanagement in der Pflege bei chronischen Schmerzen. [Entwicklung – Konsentierung – Implementierung]. Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege. 2015.. Aufl. Osnabrück: Hochschule Osnabrück; 2015
255 Büscher A, Blumenberg P. Deutsches Netzwerk für Qualitätsentwicklung in der Pflege. Expertenstandard Schmerzmanagement in der Pflege bei akuten Schmerzen. Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege. Osnabrück: DNQP an der Fachhochsch. Osnabrück: 2011
256 Deutsche Gesellschaft zum Studium des Schmerzes. BESD – BEurteilung von Schmerzen bei Demenz. Im Internet: http://www.dgss.org/fileadmin/pdf/BESD_Fassung_Dezember_2008.pdf ; Stand: 25.05.2017
257 Fischer T. Schmerzeinschätzung bei Menschen mit schwerer Demenz. Das Beobachtungsinstrument für das Schmerzassessment bei alten Menschen mit schwerer Demenz (BISAD). s.l.: Verlag Hans Huber; 2012
258 Ratzmann A, Fanghänel J. Mundhygiene beim Diabetes-Patienten. In: Hodeck K, Bahrmann A. Hrsg. Pflegewissen Diabetes. Praxistipps für die Betreuung älterer Diabetes-Patienten. Berlin: Springer Berlin; 2014: 215-220
259 Büscher A. Deutsches Netzwerk für Qualitätsentwicklung in der Pflege. Expertenstandard Ernährungsmanagement zur Sicherstellung und Förderung der oralen Ernährung in der Pflege. [einschließlich Kommentierungen und Literaturstudie]. Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege. Osnabrück: Hochschule Osnabrück; 2017
260 Büscher A. Deutsches Netzwerk für Qualitätsentwicklung in der Pflege. Expertenstandard Förderung der Harnkontinenz in der Pflege. Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege. Osnabrück: Hochschule Osnabrück; 2014
261 Büscher A. Deutsches Netzwerk für Qualitätsentwicklung in der Pflege. Expertenstandard Sturzprophylaxe in der Pflege. Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege. Osnabrück: Hochschule Osnabrück; 2013
262 Deutsches Netzwerk für Qualitätsentwicklung in der Pflege. Expertenstandard Dekubitusprophylaxe in der Pflege. Schriftenreihe des Deutschen Netzwerks für Qualitätsentwicklung in der Pflege. Osnabrück: Hochschule Osnabrück; 2010
263 Culley CM, Perera S, Marcum ZA. et al. Using a Clinical Surveillance System to Detect Drug-Associated Hypoglycemia in Nursing Home Residents. J Am Geriatr Soc 2015; 63 (10) 2125-2129 . doi:10.1111/jgs.13648
264 Anderson P. Managing diabetes in nursing and care homes. Nurs Times 2014; 110 (34) 20-21
265 Hauke D, Lohr R, Lechner A. Häufige Fallstricke bei der praktische Durchführung einer Insulintherapie. Endokrinologie Informationen 2012; Sonderheft: 23-26
266 Carstensen S, Schulze G. Injektionen von Insulin und Inkretin. In: Hodeck K, Bahrmann A. Hrsg. Pflegewissen Diabetes. Praxistipps für die Betreuung älterer Diabetes-Patienten. Berlin: Springer Berlin; 2014: 176-192
267 Robert Koch-Institut. Anforderungen an die Hygiene bei Punktionen und Injektionen. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011; 54 (09) 1135-1144 . doi:10.1007/s00103-011-1352-8
268 Deutsche Gesellschaft für Krankenhaushygiene. Konsensuspapier der Deutschen Gesellschaft für Krankenhaushygiene (DGKH) zur Mehrfachverwendung von Injektionsnadeln bei Inulinpens und Insulin-Einmalspritzen sowie zur Hautantiseptik vor der subkutanen Insulininjektion. Im Internet: https://www.krankenhaushygiene.de/Nutzerdaten/File/empfehlungen/2010_09_01_pen_papier.pdf ; Stand: 18.12.2017
269 Meulstee M, Whittemore R, Watts SA. Development of an Educational Program on Prevention of Hypoglycemic Events Among Elderly Veterans With Type 2 Diabetes. Diabetes Educ 2015; 41 (06) 690-697 . doi:10.1177/0145721715606805
270 Palleschi G, Pastore AL, Maggioni C. et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J Urol 2014; 32 (04) 1021-1025 . doi:10.1007/s00345-013-1175-3
271 Coyne KS, Wein A, Nicholson S. et al. Comorbidities and personal burden of urgency urinary incontinence: a systematic review. Int J Clin Pract 2013; 67 (10) 1015-1033 . doi:10.1111/ijcp.12164
272 Mair D, Madersbacher H. Diabetes mellitus und Harninkontinenz. Früherkennung kann Sekundärschäden vermeiden. ProCare Pflegepraxis 2010; 15 (09) 4-28
273 Podnar S, Vodusek DB. Lower urinary tract dysfunction in patients with peripheral nervous system lesions. Handb Clin Neurol 2015; 130: 203-224 . doi:10.1016/B978-0-444-63247-0.00012-2
274 Osman NI, Chapple CR, Abrams P. et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 2014; 65 (02) 389-398 . doi:10.1016/j.eururo.2013.10.015
275 Changxiao H, Zhengyong Y, Shibing Y. et al. Clinical and urodynamic evaluation of women referred with diabetes mellitus. Int Urogynecol J 2014; 25 (07) 979-983 . doi:10.1007/s00192-014-2354-5
276 Liu G, Daneshgari F. Diabetic bladder dysfunction. Chin Med J (Engl) 2014; 127 (07) 1357-1364
277 Karoli R, Bhat S, Fatima J. et al. A study of bladder dysfunction in women with type 2 diabetes mellitus. Indian J Endocrinol Metab 2014; 18 (04) 552-557 . doi:10.4103/2230-8210.137518
278 Yuan Z, Tang Z, He C. et al. Diabetic cystopathy: A review. J Diabetes 2015; 7 (04) 442-447 . doi:10.1111/1753-0407.12272
279 James R, Hijaz A. Lower urinary tract symptoms in women with diabetes mellitus: a current review. Curr Urol Rep 2014; 15 (10) 440 . doi:10.1007/s11934-014-0440-3
280 Bing MH, Gimbel H, Greisen S. et al. Clinical risk factors and urodynamic predictors prior to surgical treatment for stress urinary incontinence: a narrative review. Int Urogynecol J 2015; 26 (02) 175-185 . doi:10.1007/s00192-014-2489-4
281 Hader C, Gräfe-Gruß R. Diabetes mellitus im Alter. Diabetologie 2007; 2 (Suppl. 02) S202-S206
282 Goepel M, Kirschner-Hermanns R, Welz-Barth A. et al. Urinary incontinence in the elderly: Part 3 of a series of articles on incontinence. Dtsch Arztebl Int 2010; 107 (30) 531-536 . doi:10.3238/arztebl.2010.0531
283 Fried LP, Tangen CM, Walston J. et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56 (03) M146-M156
284 Morley JE, Vellas B, van Kan GA. et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14 (06) 392-397 . doi:10.1016/j.jamda.2013.03.022
285 Cruz-Jentoft AJ, Baeyens JP, Bauer JM. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39 (04) 412-423 . doi:10.1093/ageing/afq034
286 Aging in Motion. AIM Coalition Announces Establishment of an ICD-10-CM Code for Sarcopenia by the Centers for Disease Control and Prevention. Im Internet: http://aginginmotion.org/wp-content/uploads/2016/04/ICD-10-CM-Press-Release-2.pdf ; Stand: 25.05.2017
287 Kim TN, Park MS, Yang SJ. et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010; 33 (07) 1497-1499 . doi:10.2337/dc09-2310
288 Volpato S, Bianchi L, Lauretani F. et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care 2012; 35 (08) 1672-1679 . doi:10.2337/dc11-2202
289 Kalyani RR, Metter EJ, Egan J. et al. Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care 2015; 38 (01) 82-90 . doi:10.2337/dc14-1166
290 Garcia-Esquinas E, Graciani A, Guallar-Castillon P. et al. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults. J Am Med Dir Assoc 2015; 16 (09) 748-754 . doi:10.1016/j.jamda.2015.04.008
291 Cacciatore F, Testa G, Galizia G. et al. Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta Diabetol 2013; 50 (02) 251-260 . doi:10.1007/s00592-012-0413-2
292 Liccini A, Malmstrom TK. Frailty and Sarcopenia as Predictors of Adverse Health Outcomes in Persons With Diabetes Mellitus. J Am Med Dir Assoc 2016; 17 (09) 846-851 . doi:10.1016/j.jamda.2016.07.007
293 Castro-Rodriguez M, Carnicero JA, Garcia-Garcia FJ. et al. Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes. J Am Med Dir Assoc 2016; 17 (10) 949-955 . doi:10.1016/j.jamda.2016.07.013
294 Rodriguez-Manas L, Bayer AJ, Kelly M. et al. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes--the MID-Frail study: study protocol for a randomised controlled trial. Trials 2014; 15: 34 . doi:10.1186/1745-6215-15-34
295 Morley JE, Malmstrom TK, Rodriguez-Manas L. et al. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc 2014; 15 (12) 853-859 . doi:10.1016/j.jamda.2014.10.001
296 Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia?. J Am Med Dir Assoc 2014; 15 (09) 630-634 . doi:10.1016/j.jamda.2014.04.021
297 Pariser G, Hager K, Gillette P. et al. Active steps for diabetes: a community-campus partnership addressing frailty and diabetes. Diabetes Educ 2014; 40 (01) 60-67 . doi:10.1177/0145721713514281
298 Gordon PL, Vannier E, Hamada K. et al. Resistance training alters cytokine gene expression in skeletal muscle of adults with type 2 diabetes. Int J Immunopathol Pharmacol 2006; 19 (04) 739-749 . doi:10.1177/039463200601900404
299 Reusch JEB, Bridenstine M, Regensteiner JG. Type 2 diabetes mellitus and exercise impairment. Rev Endocr Metab Disord 2013; 14 (01) 77-86 . doi:10.1007/s11154-012-9234-4
300 Bauer J, Biolo G, Cederholm T. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013; 14 (08) 542-559 . doi:10.1016/j.jamda.2013.05.021
301 Starup-Linde J, Frost M, Vestergaard P. et al. Epidemiology of Fractures in Diabetes. Calcif Tissue Int 2017; 100 (02) 109-121 . doi:10.1007/s00223-016-0175-x
302 Ivers RQ, Cumming RG, Mitchell P. et al. Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 2001; 24 (07) 1198-1203
303 Leslie WD, Lix LM, Prior HJ. et al. Biphasic fracture risk in diabetes: a population-based study. Bone 2007; 40 (06) 1595-1601 . doi:10.1016/j.bone.2007.02.021
304 Chandran M. Diabetes Drug Effects on the Skeleton. Calcif Tissue Int 2017; 100 (02) 133-149 . doi:10.1007/s00223-016-0203-x
305 Josse RG, Majumdar SR, Zheng Y. et al. Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial. Diabetes Obes Metab 2017; 19 (01) 78-86 . doi:10.1111/dom.12786
306 Barmer GEK. Arztreport 2016. Schwerpunkt Alter und Schmerz. Bd. 37. Schriftenreihe zur Gesundheitsanalyse. Siegburg: Asgard-Verlagsservice GmbH; 2016
307 Lindbauer N, Halb L, Bornemann-Cimenti H. Therapie nozizeptiver Schmerzen bei Patienten mit Diabetes mellitus. Diabetologe 2015; 11 (06) 490-495 . doi:10.1007/s11428-015-0005-1
308 Lechleitner M, Abrahamian H, Francesconi C. et al. Diabetische Neuropathie. Wien Klin Wochenschr 2016; 128 (Suppl. 02) S73-S79 . doi:10.1007/s00508-015-0930-4
309 Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000Res 2016; 5: F1000 Faculty Rev-738 . doi:10.12688/f1000research.7898.1
310 Tran C, Philippe J, Ochsner F. et al. Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathy. Swiss Med Wkly 2015; 145: w14131 . doi:10.4414/smw.2015.14131
311 American Diabetes Association. Standards of Medical Care in Diabetes – 2017. Diabetes Care 2017; 40 (Suppl. 01) S1-S135
312 World Health Organization. Scoping document for WHO Guidelines for the pharmacological treatment of persisting pain in adults with medical illnesses. Im Internet: http://www.who.int/medicines/areas/quality_safety/Scoping_WHO_GLs_PersistPainAdults_webversion.pdf?ua=1 ; Stand: 25.06.2017
313 Beubler E, Kunz R, Sorge J. Kompendium der medikamentösen Schmerztherapie. Wirkungen, Nebenwirkungen und Kombinationsmöglichkeiten. 5.. Aufl. Wien: Springer; 2012
314 Mesaric G. Verhaltensregeln in der Schmerztherapie beim geriatrischen Patienten. Wien klin Mag 2015; 18 (03) 88-95 . doi:10.1007/s00740-015-0051-8
315 Ziegler D, Keller J, Maier C. et al. Diabetische Neuropathie. Diabetologie und Stoffwechsel 2016; 11 (Suppl. 02) S82-S92 . doi:10.1055/s-0042-113785
316 Abdulla A, Adams N, Bone M. et al. Guidance on the management of pain in older people. Age Ageing 2013; 42 (Suppl. 01) i1-i57 . doi:10.1093/ageing/afs200
317 Kunz M, Lautenbacher S. Wissen Sie, ob Ihr Demenzpatient Schmerzen hat?. MMW Fortschr Med 2015; 157 (10) 72-74 . doi:10.1007/s15006-015-3140-0
318 Lukas A, Mayer B, Onder G. et al. Schmerztherapie in deutschen Pflegeeinrichtungen im europaischen Vergleich. Ergebnisse der SHELTER-Studie. Schmerz 2015; 29 (04) 411-421 . doi:10.1007/s00482-015-0004-6
319 Rastogi R, Meek BD. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control. Clin Interv Aging 2013; 8: 37-46 . doi:10.2147/CIA.S30165
320 Eiche J, Schache F. Schmerztherapie im Alter. Dtsch Med Wochenschr 2016; 141 (09) 635-641 . doi:10.1055/s-0041-106307
321 Mamhidir AG, Sjolund BM, Flackman B. et al. Systematic pain assessment in nursing homes: a cluster-randomized trial using mixed-methods approach. BMC Geriatr 2017; 17 (01) 61 . doi:10.1186/s12877-017-0454-z
322 Sirsch E, Gnass I, Fischer T. Diagnostik von Schmerzen im Alter. Perspektiven auf ein multidimensionales Phanomen. Schmerz 2015; 29 (04) 339-348 . doi:10.1007/s00482-015-0026-0
323 DGSS-Arbeitskreis "Alter und Schmerz". Strukturiertes Schmerzinterview für geriatrische Patienten. Im Internet: http://www.dgss.org/die-gesellschaft/arbeitskreise/schmerz-und-alter/downloads/ ; Stand: 25.05.2017
324 Pain Research Group. Brief Pain Inventory (BPI). Deutsche Version: © Loick, Radbruch, Kiencke, Sabatowski (Klinik für Anästhesie, Universitätsklinik Köln). Im Internet: https://www.dnqp.de/fileadmin/HSOS/Homepages/DNQP/Dateien/Expertenstandards/Schmerzmanagement_in_der_Pflege_bei_akuten_Schmerzen/Schmerz_BPI.pdf ; Stand: 2017-16-25
325 Schuler M. BEurteilung von Schmerzen bei Demenz (BESD). Originalversion: Pain Assessment in Advanced Dementia (PAINAD) Scale Warden, Hurley, Volicer et al. Im Internet: http://www.dgss.org/fileadmin/pdf/BESD_Fassung_Dezember_2008.pdf ; Stand: 25.06.2017
326 Schmitter M, List T, Wirz S. Erfassung der Schmerzintensitat mit eindimensionalen Skalen. Z Evid Fortbild Qual Gesundhwes 2013; 107 (04) 279-284 . doi:10.1016/j.zefq.2013.05.008
327 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter – Langfassung, 1. Auflage. Version 5. Im Internet: www.dm-neuropathie.versorgungsleitlinien.de ; Stand: 21.12.2017
328 Kulzer B, Albus C, Herpertz S. et al. Psychosoziales und Diabetes (Teil 1). Diabetologie und Stoffwechsel 2013; 8 (03) 198-242 . doi:10.1055/s-0033-1335785
329 Kulzer B, Albus C, Herpertz S. et al. Psychosoziales und Diabetes (Teil 2). Diabetologie und Stoffwechsel 2013; 8 (04) 292-324 . doi:10.1055/s-0033-1335889
330 Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Auflage. Version 1. Im Internet: http://dx.doi.org/10.6101/AZQ/000262 ; Stand: 25.05.2017
331 Andreas S, Schulz H, Volkert J. et al. Prevalence of mental disorders in elderly people: The European MentDis_ICF65+ study. Br J Psychiatry 2017; 210 (02) 125-131 . doi:10.1192/bjp.bp.115.180463
332 Busch MA, Maske UE, Ryl L. et al. Pravalenz von depressiver Symptomatik und diagnostizierter Depression bei Erwachsenen in Deutschland: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56 (05) 733-739 . doi:10.1007/s00103-013-1688-3
333 Maske UE, Buttery AK, Beesdo-Baum K. et al. Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany. J Affect Disord 2016; 190: 167-177 . doi:10.1016/j.jad.2015.10.006
334 Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012; 142: S8-S21 . doi:10.1016/S0165-0327(12)70004-6
335 Liu H, Xu X, Hall JJ. et al. Differences in depression between unknown diabetes and known diabetes: results from China health and retirement longitudinal study. Int Psychogeriatr 2016; 28 (07) 1191-1199 . doi:10.1017/S104161021600020X
336 de Jonge P, Roy JF, Saz P. et al. Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project. Diabetologia 2006; 49 (11) 2627-2633 . doi:10.1007/s00125-006-0442-x
337 Maraldi C, Volpato S, Penninx BW. et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med 2007; 167 (11) 1137-1144 . doi:10.1001/archinte.167.11.1137
338 Rajkumar AP, Thangadurai P, Senthilkumar P. et al. Nature, prevalence and factors associated with depression among the elderly in a rural south Indian community. Int Psychogeriatr 2009; 21 (02) 372-378 . doi:10.1017/S1041610209008527
339 Cols-Sagarra C, Lopez-Simarro F, Alonso-Fernandez M. et al. Prevalence of depression in patients with type 2 diabetes attended in primary care in Spain. Prim Care Diabetes 2016; 10 (05) 369-375 . doi:10.1016/j.pcd.2016.02.003
340 Lunghi C, Moisan J, Gregoire JP. et al. Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study. Medicine (Baltimore) 2016; 95 (21) e3514 . doi:10.1097/MD.0000000000003514
341 Almeida OP, McCaul K, Hankey GJ. et al. Duration of diabetes and its association with depression in later life: The Health In Men Study (HIMS). Maturitas 2016; 86: 3-9 . doi:10.1016/j.maturitas.2016.01.003
342 Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228
343 Han SJ, Kim HJ, Choi YJ. et al. Increased risk of suicidal ideation in Korean adults with both diabetes and depression. Diabetes Res Clin Pract 2013; 101 (03) e14-e17 . doi:10.1016/j.diabres.2013.06.012
344 Sarkar S, Balhara YPS. Diabetes mellitus and suicide. Indian J Endocrinol Metab 2014; 18 (04) 468-474 . doi:10.4103/2230-8210.137487
345 Laursen KR, Hulman A, Witte DR. et al. Social relations, depressive symptoms, and incident type 2 diabetes mellitus: The English Longitudinal Study of Ageing. Diabetes Res Clin Pract 2017; 126: 86-94 . doi:10.1016/j.diabres.2017.01.006
346 Strodl E, Kenardy J. Psychosocial and non-psychosocial risk factors for the new diagnosis of diabetes in elderly women. Diabetes Res Clin Pract 2006; 74 (01) 57-65 . doi:10.1016/j.diabres.2006.02.011
347 Wandell PE, Tovi J. The quality of life of elderly diabetic patients. J Diabetes Complications 2000; 14 (01) 25-30
348 Zhang P, Lou P, Chang G. et al. Combined effects of sleep quality and depression on quality of life in patients with type 2 diabetes. BMC Fam Pract 2016; 17: 40 . doi:10.1186/s12875-016-0435-x
349 Moreira BDS, Dos Anjos DMC, Pereira DS. et al. The geriatric depression scale and the timed up and go test predict fear of falling in community-dwelling elderly women with type 2 diabetes mellitus: a cross-sectional study. BMC Geriatr 2016; 16: 56 . doi:10.1186/s12877-016-0234-1
350 Lustman PJ, Griffith LS, Freedland KE. et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998; 129 (08) 613-621
351 Mut-Vitcu G, Timar B, Timar R. et al. Depression influences the quality of diabetes-related self-management activities in elderly patients with type 2 diabetes: a cross-sectional study. Clin Interv Aging 2016; 11: 471-479 . doi:10.2147/CIA.S104083
352 Koopmans B, Pouwer F, deBie RA. et al. Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes study. Fam Pract 2009; 26 (03) 171-173 . doi:10.1093/fampra/cmp016
353 Kilbourne AM, Reynolds CF, Good CB. et al. How does depression influence diabetes medication adherence in older patients?. Am J Geriatr Psychiatry 2005; 13 (03) 202-210 . doi:10.1176/appi.ajgp.13.3.202
354 Katon WJ, Lin EHB, Williams LH. et al. Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study. J Gen Intern Med 2010; 25 (05) 423-429 . doi:10.1007/s11606-009-1248-6
355 Sullivan MD, Katon WJ, Lovato LC. et al. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry 2013; 70 (10) 1041-1047 . doi:10.1001/jamapsychiatry.2013.1965
356 Katon W, Pedersen HS, Ribe AR. et al. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry 2015; 72 (06) 612-619 . doi:10.1001/jamapsychiatry.2015.0082
357 Ho CS, Jin A, Nyunt MSZ. et al. Mortality rates in major and subthreshold depression: 10-year follow-up of a Singaporean population cohort of older adults. Postgrad Med 2016; 128 (07) 642-647 . doi:10.1080/00325481.2016.1221319
358 Mutambudzi M, Chen NW, Markides KS. et al. Effects of Functional Disability and Depressive Symptoms on Mortality in Older Mexican-American Adults with Diabetes Mellitus. J Am Geriatr Soc 2016; 64 (11) e154-e159 . doi:10.1111/jgs.14432
359 Downer B, Rote S, Markides KS. et al. The Comorbid Influence of High Depressive Symptoms and Diabetes on Mortality and Disability in Mexican Americans Aged 75 and Above. Gerontol Geriatr Med 2016; 2: 1-8 . doi:10.1177/2333721416628674
360 Ellison JM, Kyomen HH, Harper DG. Depression in later life: an overview with treatment recommendations. Psychiatr Clin North Am 2012; 35 (01) 203-229 . doi:10.1016/j.psc.2012.01.003
361 Hegeman JM, Kok RM, van der Mast RC. et al. Phenomenology of depression in older compared with younger adults: meta-analysis. Br J Psychiatry 2012; 200 (04) 275-281 . doi:10.1192/bjp.bp.111.095950
362 Whooley MA, Avins AL, Miranda J. et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12 (07) 439-445
363 Hautzinger M. Depression im Alter. Weinheim: Beltz/PVU; 2000
364 Heidenblut S, Zank S. Entwicklung eines neuen Depressionsscreenings fur den Einsatz in der Geriatrie. Die „Depression-im-Alter-Skalang“ (DIA-S). Z Gerontol Geriatr 2010; 43 (03) 170-176 . doi:10.1007/s00391-009-0067-z
365 Korner A, Lauritzen L, Abelskov K. et al. The Geriatric Depression Scale and the Cornell Scale for Depression in Dementia. A validity study. Nord J Psychiatry 2006; 60 (05) 360-364 . doi:10.1080/08039480600937066
366 Wolter DK. Depressionen im höheren Lebensalter, Teil 1. Entstehung, klinische Symptome, Diagnose und Wechselwirkung zwischen Depression und Demenz. Z Gerontol Geriatr 2016; 49 (04) 335-348 . doi:10.1007/s00391-015-1019-4
367 Kruse A. Störungen im Alter: Intervention. In: Perrez M, Baumann U. Hrsg. Lehrbuch klinische Psychologie – Psychotherapie. Aus dem Programm Huber Psychologie-Lehrbuch. 3.. Aufl. Bern: Huber; 2005: 1087-1103
368 Williams JW, Katon W, Lin EHB. et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004; 140 (12) 1015-1024
369 Katon W, Unützer J, Fan MY. et al. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 2006; 29 (02) 265-270
370 Gühne U, Luppa M, König HH. et al. Ist Psychotherapie bei depressiven Erkrankungen im Alter wirksam?. Psychiatr Prax 2014; 41 (08) 415-423 . doi:10.1055/s-0034-1370113
371 Markowitz SM, Gonzalez JS, Wilkinson JL. et al. A review of treating depression in diabetes: Emerging findings. Psychosomatics 2011; 52 (01) 1-18 . doi:10.1016/j.psym.2010.11.007
372 Wilson K, Mottram P, Sivanranthan A. et al. Antidepressant versus placebo for depressed elderly. Cochrane Database Syst Rev 2001; 1: CD000561 . doi:10.1002/14651858.CD000561
373 Zajecka J, Schatzberg A, Stahl S. et al. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2010; 30 (02) 135-144 . doi:10.1097/JCP.0b013e3181d420a7
374 DGPPN, BÄK, KBV, AWMF (Hrsg) für die Leitliniengruppe Unipolare Depression. Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Auflage. Version 5. Im Internet: www.depression.versorgungsleitlinien.de ; Stand: 14.05.2018
375 Centers of Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States 2014. Im Internet: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf ; Stand: 25.05.2017
376 Weyerer S. Robert-Koch-Institut. Altersdemenz. Bd. 28. Gesundheitsberichterstattung des Bundes. Berlin: Robert Koch-Institut; 2005
377 Deutsche Gesellschaft für Neurologie, Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde. S3-Leitlinie "Demenzen". Im Internet: http://www.awmf.org/leitlinien/detail/ll/038-013.html ; Stand: 25.05.2017
378 Cheng G, Huang C, Deng H. et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012; 42 (05) 484-491 . doi:10.1111/j.1445-5994.2012.02758.x
379 Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Demenz. Leitlinie Langfassung. Bd. 12. DEGAM-Leitlinie. 2008.. Aufl. Düsseldorf: Omikron Publ; 2008
380 National Institute for Health and Clinical Excellence. Dementia: A NICE-SCIE guideline on supporting people with dementia and their carers in health and social care. 2007
381 Hofmann W. Leitliniengerechte Diagnose des Demenzsyndroms. Z Gerontol Geriatr 2012; 45 (04) 341-351 . doi:10.1007/s00391-012-0295-5
382 Ihl R, Grass-Kapanke B, Lahrem P. et al. Entwicklung und Validierung eines Tests zur Fruherkennung der Demenz mit Depressionsabgrenzung (TFDD). Fortschr Neurol Psychiatr 2000; 68 (09) 413-422 . doi:10.1055/s-2000-11799
383 American Diabetes Association. 10. Older Adults. Diabetes Care 2016; 39 (Suppl. 01) S81-S85 . doi:10.2337/dc16-S013
384 Braun A, Muller UA, Muller R. et al. Structured treatment and teaching of patients with Type 2 diabetes mellitus and impaired cognitive function--the DICOF trial. Diabet Med 2004; 21 (09) 999-1006 . doi:10.1111/j.1464-5491.2004.01281.x
385 Vollmann J. Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med 2000; 342 (23) 1755 ; author reply 1756
386 Parhofer K, Göke B, Hauner H. et al. DGEM-Leitlinie Enterale Ernährung. Diabetologie. Aktuel Ernahrungsmed 2003; 28: 103-109 . doi:10.1055/s-2003-36931
387 Meneilly GS, Knip A, Tessier D. Diabetes in the elderly. Can J Diabetes 2013; 37 (Suppl. 01) S184-S190 . doi:10.1016/j.jcjd.2013.01.045
388 Kirkman MS, Briscoe VJ, Clark N. et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc 2012; 60 (12) 2342-2356 . doi:10.1111/jgs.12035
389 Leitlinienprogramm Onkologie. Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Langversion 1.1. Im Internet: http://leitlinienprogrammonkologie.de/Palliativmedizin.80.0.html ; Stand: 25.05.2017
390 Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ 2010; 341: c4863 . doi:10.1136/bmj.c4863
391 Hussain JA, Mooney A, Russon L. Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med 2013; 27 (09) 829-839 . doi:10.1177/0269216313484380
392 Brown MA, Collett GK, Josland EA. et al. CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life. Clin J Am Soc Nephrol 2015; 10 (02) 260-268 . doi:10.2215/CJN.03330414
393 O’Connor NR, Kumar P. Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med 2012; 15 (02) 228-235 . doi:10.1089/jpm.2011.0207
394 Moss AH. Revised dialysis clinical practice guideline promotes more informed decision-making. Clin J Am Soc Nephrol 2010; 5 (12) 2380-2383 . doi:10.2215/CJN.07170810
395 Sharp T, Moran E, Kuhn I. et al. Do the elderly have a voice? Advance care planning discussions with frail and older individuals: A systematic literature review and narrative synthesis. Br J Gen Pract 2013; 63 (615) e657-e668 . doi:10.3399/bjgp13X673667
396 Bischoff KE, Sudore R, Miao Y. et al. Advance care planning and the quality of end-of-life care in older adults. J Am Geriatr Soc 2013; 61 (02) 209-214 . doi:10.1111/jgs.12105
397 Schrijvers D, Cherny NI. ESMO Clinical Practice Guidelines on palliative care: Advanced care planning. Ann Oncol 2014; 25 (Suppl. 03) iii138-iii142 . doi:10.1093/annonc/mdu241
398 Klindtworth K, Oster P, Hager K. et al. Living with and dying from advanced heart failure: Understanding the needs of older patients at the end of life. BMC Geriatr 2015; 15: 125 . doi:10.1186/s12877-015-0124-y
399 Winkler EC, Heußner P. Vorausschauende Behandlungsplanung und Therapiebegrenzung. Dtsch Med Wochenschr 2016; 141 (06) 394-398 . doi:10.1055/s-0041-110421

Zusatzmaterial

Ergänzendes Material